Total Payments
$2,479
2024 Payments
$337.92
Companies
22
Transactions
125
Medicare Patients
372
Medicare Billing
$21,496
Payment Breakdown by Category
Food & Beverage$2,479 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,479 | 125 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $306.34 | 11 | $0 (2024) |
| ABBVIE INC. | $304.30 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $264.74 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $264.20 | 16 | $0 (2024) |
| Amgen Inc. | $166.50 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $164.57 | 4 | $0 (2023) |
| Novo Nordisk Inc | $144.26 | 23 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $143.27 | 7 | $0 (2024) |
| Lilly USA, LLC | $139.80 | 8 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $111.51 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.92 | 16 | ABBVIE INC. ($76.84) |
| 2023 | $1,783 | 95 | Astellas Pharma US Inc ($257.62) |
| 2022 | $357.94 | 14 | AstraZeneca Pharmaceuticals LP ($136.91) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Gastroenterology | ||||||
| 03/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Biological | ||||||
| 03/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: VACCINE | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Gastroenterology | ||||||
| 02/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Biological | ||||||
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Bone Health | ||||||
| 01/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: UROLOGY | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: DIABETES | ||||||
| 12/20/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $40.29 | General |
| Category: Neurology | ||||||
| 12/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 12/02/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.88 | General |
| 11/21/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Gastroenterology | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 289 | 404 | $67,862 | $16,118 |
| 2022 | 2 | 83 | 95 | $13,489 | $5,378 |
Total Patients
372
Total Services
499
Medicare Billing
$21,496
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 95 | 172 | $20,468 | $7,494 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 63 | 99 | $15,939 | $4,546 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 79 | 79 | $25,596 | $3,464 | 13.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 12 | $1,680 | $406.50 | 24.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 40 | 42 | $4,179 | $208.80 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 52 | $8,372 | $3,344 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 37 | 43 | $5,117 | $2,034 | 39.8% |
About Catherine Hare, NP
Catherine Hare, NP is a Family healthcare provider based in Hudson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2022. The National Provider Identifier (NPI) number assigned to this provider is 1437886843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Catherine Hare, NP has received a total of $2,479 in payments from pharmaceutical and medical device companies, with $337.92 received in 2024. These payments were reported across 125 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,479).
As a Medicare-enrolled provider, Hare has provided services to 372 Medicare beneficiaries, totaling 499 services with total Medicare billing of $21,496. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Hudson, NY
- Active Since 08/05/2022
- Last Updated 08/05/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1437886843
Products in Payments
- TRELEGY ELLIPTA (Drug) $264.74
- Veozah (Drug) $243.34
- JARDIANCE (Drug) $181.08
- UBRELVY (Drug) $169.36
- FARXIGA (Drug) $164.57
- TRINTELLIX (Drug) $143.27
- VRAYLAR (Drug) $115.96
- Repatha (Biological) $111.98
- XIFAXAN (Drug) $111.51
- MOUNJARO (Drug) $101.05
- ELIQUIS (Drug) $97.95
- Ozempic (Drug) $75.67
- Rybelsus (Drug) $68.59
- Kerendia (Drug) $63.28
- Myrbetriq (Drug) $63.00
- LEQVIO (Drug) $55.97
- EVENITY (Biological) $54.52
- GEMTESA (Drug) $48.68
- Nayzilam (Drug) $40.29
- REXULTI (Drug) $36.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hudson
Mrs. Tayler Yoder, C.n.p, C.N.P
Family — Payments: $7,132
Family $7,132
Marilyn Miller, Np, NP
Family — Payments: $4,833
Family $4,833
Mr. Adam Murchie, Arnp, ARNP
Family — Payments: $4,547
Family $4,547
Mrs. Ashley Carver, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $3,706
Family $3,706
Kristin Magnanini, N.p, N.P
Family — Payments: $3,683
Family $3,683
Sally Baird, Np-C, NP-C
Family — Payments: $2,168
Family $2,168